Blackstone’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BBIO
Blackstone's BBIO Position: Q2 2026 in Review
Blackstone opened a new position in BridgeBio Pharma (BBIO) in Q2 2026: 4,963 shares worth $370K. The stake represents ﹤0.01% of the portfolio and ranks #413 among its holdings. This is a return to the name: Blackstone previously reported a position in BBIO as recently as Q3 2025.
Blackstone first reported a position in BBIO in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.06M in Q3 2025. 477 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.
- Blackstone held 4,963 shares of BridgeBio Pharma worth $370K as of Q2 2026.
- BridgeBio Pharma was a new Blackstone position in Q2 2026.
- BridgeBio Pharma made up ﹤0.01% of Blackstone's portfolio in Q2 2026, its #413 holding.
- Blackstone first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 2 quarters since.
- Blackstone's BridgeBio Pharma position peaked at $1.06M in Q3 2025.
- 477 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.
Based on Blackstone's 13F filing for Q2 2026, filed 14 Aug 2026.